icon-folder.gif   Conference Reports for NATAP  
 
  18th European AIDS Conference
October 27th-30th, 2021
Online & United Kingdom
Back grey_arrow_rt.gif
 
 
 
Prevalence and risk factors of preexisting TAMs in clinical trial participants and sustained viral suppression after switching to bictegravir/emtricitabine/tenofovir alafenamide
 
 
  18th EACS 2021 Oct 27-30
 
K. Andreatta1, R. Acosta1, M.L. D'Antoni1, H. Liu1, S. Chang1, R. Martin1, S. Collins1, H. Martin1, K.L. White1 1Gilead Sciences, Inc., Foster City, United State

1030211

1030212

1030213

1030214

1030215

1030216

1030217

1030218

1030219

10302110